Lucidumones L-P: Meroterpenoids from Ganoderma lucidum and their inhibitory effect on triple negative breast cancer.
2/5 보강
PICO 자동 추출 (휴리스틱, conf 2/4)
유사 논문P · Population 대상 환자/모집단
Compound 1 was structurally characterized as a decarbonized dimeric meroterpenoid.
I · Intervention 중재 / 시술
추출되지 않음
C · Comparison 대조 / 비교
추출되지 않음
O · Outcome 결과 / 결론
Compound 1 was structurally characterized as a decarbonized dimeric meroterpenoid. Compounds 2 and 3 possess significant inhibitory effects on the cell migration of MDA-MB-231 cells, and compound 2 inhibits the cell migration dose-dependently.
OpenAlex 토픽 ·
Fungal Biology and Applications
Sesquiterpenes and Asteraceae Studies
Antioxidants, Aging, Portulaca oleracea
Meroterpenoids in Ganoderma mushrooms have attracted attention in recent years.
APA
Jiao-Jiao Zhang, Zehong Wu, et al. (2026). Lucidumones L-P: Meroterpenoids from Ganoderma lucidum and their inhibitory effect on triple negative breast cancer.. Phytochemistry, 249, 114927. https://doi.org/10.1016/j.phytochem.2026.114927
MLA
Jiao-Jiao Zhang, et al.. "Lucidumones L-P: Meroterpenoids from Ganoderma lucidum and their inhibitory effect on triple negative breast cancer.." Phytochemistry, vol. 249, 2026, pp. 114927.
PMID
42002126 ↗
Abstract 한글 요약
Meroterpenoids in Ganoderma mushrooms have attracted attention in recent years. In this effort, lucidumones L-P (1-5), five undescribed meroterpenoids, including four without chirality (1-4) and a pair of enantiomers (5), were isolated from G. lucidum. Their structures were elucidated using spectroscopic and computational methods. Compound 1 was structurally characterized as a decarbonized dimeric meroterpenoid. Compounds 2 and 3 possess significant inhibitory effects on the cell migration of MDA-MB-231 cells, and compound 2 inhibits the cell migration dose-dependently.